Noevir Holdings Co., Ltd. (TYO:4928)

Noevir Holdings Revenue

Noevir Holdings had revenue of 15.46B JPY in the quarter ending June 30, 2026, with 1.40% growth. This brings the company's total for the last twelve months to 63.52B, up 1.03% year-over-year. In the fiscal year ending September 30, 2025, Noevir Holdings had annual revenue of 64.72B with 1.41% growth. That makes Noevir Holdings the 12,520th largest company in the world by revenue and 1,298th in Japan.

• Revenue (ttm): 63.52B
• Revenue Growth: +1.03%
• P/S Ratio: 2.49
• Revenue / Employee: 46.91M
• Employees: 1,354
• Market Cap: 158.31B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Cosmetics 50.53B 77.7%
• Pharmaceuticals & Health Food 11.54B 17.7%
• Other 2.93B 4.5%

Fiscal year ended Sep 30, 2025 See the full Noevir Holdings breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2025	64.72B	901.00M	1.41%
Sep 30, 2024	63.82B	1.27B	2.03%
Sep 30, 2023	62.55B	1.41B	2.30%
Sep 30, 2022	61.14B	9.87B	19.25%
Sep 30, 2021	51.27B	-569.00M	-1.10%

Data Source: S&P Global Market Intelligence Last updated: Aug 3, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 19, 2026

Data Sources Report a data error